(Total Views: 616)
Posted On: 06/01/2022 3:35:51 PM
Post# of 154117
I agree with you. I don't know why management is "flirting" with prior 13D, but I don't know whole story. I just have to try to make sense of it.
I don't trust RP or BP. I don't know if they had any better options when it came to RP. They should stand clear of bloodsucking sponges who already have displayed their true colors. I would stand aloof even from those who remain pro-parasitical.
The patent would not have gone to RP, but rather David Welch because he put up the bond. But I don't believe we need to fear that any more because if you remember, in this 8K:
https://www.cytodyn.com/investors/sec-filings...148819.pdf
the value of the two private placements is just about $6.5 million. I find it interesting that it equals exactly the value of the bond. I believe, management has returned David's money and replaced it with the monies they received from this private placement. The IP on the LL patent is not at risk any more in my estimation.
Amarex is in Sidley Austin's hands. SA did not do this for attorney fees.
Both SK and CR have expressed that the audited data will be good to obtain the aggregated safety data which should allow the lifting of the hold for HIV and covid. Will also allow the re-submission of the BLA for HIV later this year.
I don't trust RP or BP. I don't know if they had any better options when it came to RP. They should stand clear of bloodsucking sponges who already have displayed their true colors. I would stand aloof even from those who remain pro-parasitical.
The patent would not have gone to RP, but rather David Welch because he put up the bond. But I don't believe we need to fear that any more because if you remember, in this 8K:
https://www.cytodyn.com/investors/sec-filings...148819.pdf
the value of the two private placements is just about $6.5 million. I find it interesting that it equals exactly the value of the bond. I believe, management has returned David's money and replaced it with the monies they received from this private placement. The IP on the LL patent is not at risk any more in my estimation.
Amarex is in Sidley Austin's hands. SA did not do this for attorney fees.
Both SK and CR have expressed that the audited data will be good to obtain the aggregated safety data which should allow the lifting of the hold for HIV and covid. Will also allow the re-submission of the BLA for HIV later this year.
(1)
(0)
